JPRN-UMIN000049231招募中Unknown
Impact of Aggressive Lipid-Lowering Therapy with Evolocumab on Peripheral Atherosclerotic Plaque Assessed with NIRS-IVUS in Patients with Peripheral Artery Disease - RESOLVE PAD
niversity of Fukui Division of Cardiovascular Medicine, Faculty of Medical Sciences0 个研究点目标入组 30 人开始时间: 2022年11月1日最近更新:
适应症
试验速览
- 阶段
- Unknown
- 状态
- 招募中
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1) patients who are pregnant or breastfeeding (2) patients for whom evolocumab therapy is contraindicated (3) patients scheduled to undergo low-density lipoprotein (LDL) apheresis (4) patients with severe liver dysfunction (such as Child-Pugh classification C)
研究者
相似试验
已完成
不适用
Effects of Aggressive Lipid Lowering Therapy With Atorvastatin on the Fibrous cap Thickness of Thin-cap Fibroatheroma: Three-Vessel Optical Coherence Tomography and Intravascular Ultrasound StudyAcute Coronary SyndromeJPRN-UMIN000003620Hyogo College of Medicine Cardiovascular Division50
已完成
不适用
The effecs of intensive lipid-lowering therapy on the progression of atherosclerotic kidney diseasechronic kidney diseaseJPRN-UMIN000021356niversity, School of Medicine40
已完成
不适用
Impact of lipid-lowering therapy with Evolocumab on coronary plaque regression in patients with coronary artery diseaseJPRN-UMIN000023448Chiba University Graduate School of Medicine3
已完成
不适用
Aggressive lipid-lowering treatment approaches for vulnerable plaque in coronary artery with rosuvastatin. -Assessment using angioscopy and intravascular ultrasoundHypercholesterolemiaJPRN-UMIN000003276ALTAIR Study50
招募中
不适用
Evaluation of cholesterol lowering efficacy of Rice bran oil, Olive oil and Groundnut oilCTRI/2013/02/003365AP ORGANICS PVT LTD120